US FDA approves Korean regenerative wound dressing

Sewon Cellontech said on August 31 that it has received approval from the U.S. Food and Drug Administration to market its TheraForm, an absorbable biomatrix membrane for wound dressing, in the US market.

The company said the approval comes after it submitted premarket notification for Theraform to the US FDA in April this year.

TheraForm is an absorbable biocompatible implant to enhance t...